The effect of oxidative stress on human red blood cell AMP-deaminase activity was studied by incubating either fresh erythrocytes or hemolysates with H 2 O 2 (0.5, 1, 2, 4, 6, 8 and 10 mM) or NaNO 2 (1, 5, 10, 20 and 50 mM), for 15 min at 37 °C. AMP-deaminase assay revealed a tremendous increase of activity by increasing H 2 O 2 or NaNO 2 at up to 4 mM and 20 mM, respectively (maximal effect for both oxidants = 9.5 and 6.5 times higher enzymatic activity than control erythrocytes or hemolysates, respectively). Higher To the best of our knowledge, this is the first example of an enzyme, fundamental for the maintenance of the correct red blood cell energy metabolism, which is activated (rather than inhibited) by the interaction with reactive oxygen species.
INTRODUCTION
Reactive oxygen species (ROS) 1 are dangerous molecules generated physiologically and pathologically from various intracellular and extracellular sources (1) . Several ROS-induced irreversible modifications of biologically fundamental macromolecules have been described, including oxidation of protein -SH groups (2) , oxidation of purine nucleotides of nucleic acids (3) , initiation of lipid peroxidation reaction chain (4) (5) . Due to their very high ferrous iron concentration, human erythrocytes might be exposed to risks of increased oxidative stress, mainly through the formation of ferrylhemoglobin (6) and, in part, through the Fenton reaction of hydrogen peroxide with Fe 2+ of hemoglobin which generates the powerful oxidant hydroxyl radical (7) . Although provided of efficient enzymatic systems for H 2 O 2 removal (catalase, glutathione peroxidase) several ROS-mediated erythrocyte damages have been reported to occur in different in vitro experimental conditions, including challenge with hydrogen peroxide (8, 9) , incubation with redox-cycling drugs (10) and during the aging process (11) . Nevertheless, data available in literature give very little information on alteration of erythrocyte energy metabolism (in terms either of metabolites or of enzymatic activities) following oxidative stress, except for results reporting only modest effects of iron-ascorbate (as a ROS-generating system) on hexokinase (12) , thus suggesting that enzymes involved in red blood cell energy production are scarcely affected by oxidative stress.
Very recently, we have viceversa shown that oxidative stress, induced by increasing the addition of H 2 O 2 concentrations to intact red blood cells, provoked a progressive ATP depletion which was unexpectedly paralleled by a marked IMP (but neither AMP nor ADP) increase. Such a phenomenon was very probably linked to AMP-deaminase activation (13) . This enzyme plays a critical role in energy metabolism, catalyzing the deamination of AMP into IMP in the purine nucleotide cycle, and it is present in mammals in three different isoforms: AMP-deaminase 1 is the predominant form in skeletal muscle; AMP-deaminase 2 is present in smooth muscle, nonmuscle tissue, embryonic muscle and undifferentiated myoblasts; AMP-deaminase 3 is found in erythrocytes. The erythrocyte isoform is a homotetramer whose monomers are composed by 767 amino acids; each protein subunit contains nine cysteine residues. AMP-deaminase 3 is regulated by several positive (Ca 2+ ) and negative (2,3-BPG, P i ) effectors and it is physiologically maintained in a state with low catalytic activity, mainly because of erythrocyte low Ca 2+ and high 2,3-BPG.
On the basis of these observations, we were prompted to study in detail the effect of increasing oxidative stress on AMP-deaminase activity of intact erythrocytes, of hemolysates, and of the purified AMP-deaminase from human red blood cells. Results, corroborated by data of experiments effected on quinine-treated erythrocytes and hemolysates and obtained from patients suffering from glucose-6-phosphate dehydrogenase (G-6-PDH) deficiency, demonstrate that AMP-deaminase is activated by oxidative stress through the modification of its accessible -SH groups and it is responsible for a profound and probably irreversible derangement of erythrocyte energy metabolism.
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The abbreviations used are: ROS, reactive oxygen species; P i , inorganic phosphorus; G-6-PDH, glucose-6-phosphate dehydrogenase; NEM, N-ethylmaleimide; PMB, phydroxymercuribenzoate; DTNB, 5,5'-dithiobis(2-nitrobenzoic acid).
incubations, 200 µl were withdrawn from each sample and used for measuring AMP-deaminase activity.
In a different set of experiments, NaN 3 -pretreated hemolysates were incubated with H 2 O 2 (0. 
Experiments with the purified AMP-deaminase
Purification of red blood cell AMP-deaminase was performed according to Nathans et al. (14) , with minor modifications. Briefly, 5 ml of washed and packed erythrocytes, were hemolyzed with 5 ml of ice-cold double-distilled H 2 O and kept for 30 min under stirring, in the cold.
Membranes were sedimented by centrifugation at 35,000 g for 30 min at 4 °C and supernatant was mixed with an equal volume of a DEAE-cellulose slurry, previously equilibrated at pH 7.0.
After 30 min of gentle stirring at 4 °C, the resin was filtered and washed with 20 mM tris-HCl + 20 mM KCl, pH 7.5, until the filtrate was colorless. The dried resin was resuspended with 20 ml of 20 mM tris-HCl + 500 mM KCl, pH 7.0, and kept overnight under continuous gentle mixing at 4 °C. DEAE-cellulose was again filtered and the filtrate was precipitated by adding solid ammonium sulfate at up to 65% saturation. After centrifugation at 12,900 g for 10 min at 4 °C, the supernatant was discarded and the pellet was dissolved in 300 mM KCl + 1 mM ammonium acetate, pH 7.0, and dialyzed with the same buffer for 24 h at 4 °C. At the end of dialysis, the sample was centrifuged at 41,700 g for 15 min at 4 °C and 3 ml of the supernatant were loaded onto a 8-(6-aminohexyl)-amino-AMP cross-linked 4% beaded agarose column (20 x 0.5 cm), previously equilibrated with 3 mM KCl + 2 mM ammonium acetate, pH 7.0. After having washed the column with 20 ml of the same buffer, AMP-deaminase was eluted with 15 ml of 20 mM KCl + 150 mM KH 2 PO 4 , pH 6.5 at a flow rate of 1 ml/min. An approximate 90% purity of this enzyme preparation was determined by native polyacrylamide gel-electrophoresis (see below and Figure 6 ). Before any further use, the purified enzyme was extensively dialyzed against 10 mM KCl + 2 mM ammonium acetate, pH 6.5, to remove P i excess.
To evaluate the effect of a ROS-generating system and of -SH-blocking treatment, aliquots of the purified AMP-deaminase were incubated with: increasing To measure accessible -SH groups before and after oxidative stress or treatment with -SHmodifying reagents, a 3 mg/ml suspension of the 90% purified AMP-deaminase was prepared in 20 mM ammonium acetate buffer, pH 7.0, divided into different aliquots and treated as follows: 
Assay of AMP-deaminase and GSH determination
For determining AMP-deaminase activity, aliquots from hemolyzed erythrocytes, hemolysates and purified enzyme were withdrawn and incubated for 30 min at 37 °C in presence of 2 mM AMP, 10 mM KCl, 10 mM MES, pH 6. 
RESULTS

Effect of ROS on AMP-deaminase activity of intact erythrocytes and hemolysates
In Figure Table I . The absence of synergism between the two treatments reinforces the hypothesis of a key role of sulfhydryl group modification in the enzyme activation. Table II in the incubation mixture was at least 5 mM. Data referring to effects of P i (Table IV) indicated evident differences among AMP-deaminase activity of control and treated hemolysates.
In particular, IC 50 of P i were 7.56, 3.24 and 3.07 mM, in control, 4 mM H 2 O 2 -and 1 mM NEMtreated hemolysates, respectively. Even if the activated enzyme was responsive to P i inhibition, AMP-deaminase activity of 4 mM H 2 O 2 -and 1 mM NEM-treated hemolysates was comparable to that of control hemolysates only when P i in the medium was higher than 10 mM.
Effect of ROS and -SH-blocking reagents on the activity, the quaternary structure and the free -SH groups of the purified AMP-deaminase
To reproduce a ROS-generating system in part similar to that present in H 2 O 2 -treated erythrocytes and hemolysates, we incubated the 90% purified AMP-deaminase (obtained from (respectively, erythrocytes and hemolysates showed 3.8 and 3.2 times higher activity than corresponding controls; p < 0.001). It is important to underline that even the lowest quinine concentration tested (0.01 mM) produced an increase, although not significant, of AMPdeaminase activity (+13%); statistically significant differences from control G-6-PDH-deficient erythrocytes and hemolysates were reached with 0.1 mM quinine (+41% and +38% for erythrocytes and hemolysates, respectively; p < 0.05).
DISCUSSION
The relative metabolic simplicity of red blood cells is one of their peculiarity but, of course, it also represents one of the main limitations for their survival. In this light, any change of enzymatic activities, particularly of those involved in the maintenance of the correct energy state, might signify such a drastic problem to produce even the erythrocyte death. Among the various possible causes affecting erythrocyte energy metabolism, oxidative stress might certainly represent a negative factor whose relevance, unlike to other tissues (5, 17) and cell types (18, 19) has not been fully evaluated. Previous investigation, using iron-ascorbate as a ROS-generating system, apparently showed a poor capacity of oxidative stress to alter enzymes and metabolites of human red blood cell energy metabolism (12) . Viceversa, we very recently demonstrated that incubation of fresh human erythrocytes with increasing hydrogen peroxide concentrations (i.e., with a free radical-generating system producing ferrylhemoglobin and possibly OH . ), provoked a progressive ATP depletion which was paralleled by a dramatic IMP and a modest AMP or ADP increase. Furthermore, such a metabolic modification was attributed to AMP-deaminase activation (13) . This enzyme plays a critical role in energy metabolism, catalyzing the deamination of AMP into IMP in the purine nucleotide cycle, particularly in erythrocytes because they lack of the salvage pathway of purine nucleotides. Therefore, IMP production represents for red blood cell a remarkable waste of energy.
The experiments reported in the present study, in which we evaluated in detail (on intact erythrocytes, on hemolysates and on the 90% purified AMP-deaminase) the activity of the type 3 erythrocytic isoenzyme under different experimental conditions, showed that the extent of AMPdeaminase activation depended on the severity of oxidative stress at up to a certain limit, beyond which an inhibitory effect was observed. We found that in intact erythrocytes and hemolysates (Figure 1 ), as well as in the 90% purified enzyme ( Figure 5 , Panels A and B), even a modest ROS production, unable to produce GSH depletion higher than 50% (Table II) , caused a significant increase of AMP-deaminase activity, thus indicating a high reactivity of specific amino acid residues of the protein towards oxidative stress. Furthermore, the -SH-modifying reagents iodoacetate, NEM and PMB (Figure 2 ; Figure 5 , Panels C and D) mimicked the same enzymatic activation obtainable with the ROS-generating systems tested, supporting the hypothesis that oxidative stress-mediated AMP-deaminase activation occurs via irreversible modification of cystein(s) crucial for controlling enzymatic activity. In experiments with hemolysates, this indication was reinforced by the lack of synergism between ROS and reagents for -SH (Table I) and -SH-treated erythrocytes, hemolysates and 90% purified enzyme is in its native tetrameric structure.
On the basis of the results obtained by titrating free -SH groups of the 90% purified AMPdeaminase (Table V) , it is possible to sustain that the mechanism of oxidative stress-induced enzymatic activation involves, among the 10 freely accessible -SH groups, the modification of 2-4 cystein residues/AMP-deaminase tetramer. The minimal and maximal numbers of modified -SH groups determine the corresponding minimal and maximal extent of AMP-deaminase activation. Such an -SH group modification, mimicked by the -SH-blocking compound NEM, should induce conformational changes of the tetrameric protein structure leading to AMPdeaminase stabilization in the R state with high affinity for AMP, and consequent enzyme activation. It is also presumable that the bell-shaped dose response curve of the enzyme activity, as a function of increasing oxidants or -SH-modifying reagents, might occur either because of the reaction with a specific cystein residue not easily accessible by reagents and directly involved in the AMP-deaminase catalytic mechanism, or because of the possible unspecific modification of amino acids other than cysteins (lysines, tyrosines, methionines). In both cases, this occurrence was encountered at definitely high concentrations of both stimuli. It is worth underlining that the H 2 O 2 and NaNO 2 AMP-deaminase activation was not reverted by reducing reagents, such as GSH or β-mercaptoethanol (data not shown), thereby indicating an irreversible oxidative cystein modification, as it occurs in the reaction of ROS with -SH groups (20) .
The evident demonstration of ROS-activated AMP-deaminase, obtained by the experiments conducted with the 90% purified enzyme challenged with a ROS-generating system based on the Fenton reaction, allowed to hypothesize that hydroxyl radicals are directly responsible for AMPdeaminase activation. Under these experimental conditions, the purified enzyme represented one of the main macromolecular targets present in the incubation mixture and no possible interferences by eventual low molecular weight modulators might have occurred. Since OH . are produced in part during the reaction of hydrogen peroxide with the ferrous iron of hemoglobin (7), it is conceivable to speculate that hydroxyl radicals are involved in the AMP-deaminase modification of intact erythrocytes and hemolysates.
The importance of the results reported in the present study lies in the key role played by AMPdeaminase in determining the correct energy state of human erythrocytes. Previous studies showed that red blood cells underwent to ATP depletion, through AMP-deaminase activation, after exposure to various Ca 2+ concentrations (21) (22) (23) . Similar results were obtained upon exposure of erythrocytes to alkalinization and deoxyadenosine addition (24) , as well as after incubation with different nucleoside analogues (25) . It was supposed that change of AMPdeaminase activity is involved in the erythrocyte aging process (26) , albeit this original hypothesis was subsequently contradicted by other studies (27, 28) . Results of the present study certainly demonstrated that ROS can now be added to the list of the most potent activators of erythrocyte AMP-deaminase. From the data reported in literature, this phenomenon should be peculiar of the red blood cell isoform. In fact, it was shown a significant AMP-deaminase inhibition of yeast cells subjected to oxidative stress (29) and, furthermore, it was demonstrated a similar inhibitory pattern of the rabbit cardiac isoenzyme (30) . In this last study, AMP-deaminase inactivation was correlated to an altered thiol status of the enzyme, quickly occurring (5-10 min) upon submission to oxidative stress, that should be responsible for irreversible modifications of AMP-deaminase conformation altering its catalytic activity (30) . Our data showed that the reaction of ROS with the erythrocyte isoenzyme was similarly fast, but the final result of oxidative stress was the striking enzyme activation rather than the enzyme inhibition. Such a totally opposite effect might be attributable to the amino acid sequence differences of the various isoforms that should give rise to different conformational structures and thus to different sensitivities towards ROS effects; in addition, it is evident from our experiments performed with iodoacetate, NEM and PMB, in which modification of -SH groups mimicked the activity of 4 mM H 2 O 2 , that the change of erythrocyte AMP-deaminase thiol state do stimulate (instead of inhibiting) the enzymatic activity; at present, the only AMP-deaminase capable to be markedly activated by ROS seems, therefore, the erythrocyte isoform.
Our results obtained by challenging erythrocytes and hemolysates from G-6-PDH-deficient patients with the anti-malarial drug quinine hydrochloride (Figure 7) , showed the same patterns of AMP-deaminase activation than those occurring to erythrocytes and hemolysates obtained from blood of healthy subjects and then subjected to oxidative stress. From the physiopathological point of view, this finding implies that, through ROS-induced activation of AMP-deaminase, oxidative stress might represent one of the main negative event leading to profound impairment of the erythrocyte energy state in physiological (aging) and, moreover, pathological conditions. In fact, all the situations in which erythrocytes may be subjected to oxidative stress by different causes, such as those induced by redox cycling xenobiotics (anthracycline drugs, paraquat, etc.), by hemolytic crisis (G-6-PDH deficiency), by hemoglobinopathies (hemoglobin S), by increase of met-hemoglobin and free radicals (smokers), by hemodyalisis (nephropathies), should be reconsidered in light of the negative contributions for energy metabolism that occur when AMP-deaminase is activated (13).
In conclusion, although further studies will be necessary for elucidating the mechanism of ROSmediated activation of human erythrocyte AMP-deaminase, as well as the specific amino acid residues implicated and the structural changes driving this activation, we demonstrated, for the first time to the best of our knowledge, that direct interaction of ROS with an enzyme of energy metabolism is able to activate rather than inhibiting the catalytic activity of the enzyme itself. At present, only examples of enzymatic inactivation by oxidative stress can be found in literature, such as those occurring to glyceraldehyde-3-phosphate dehydrogenase (31, 32), glucose-6-phosphate dehydrogenase (31), creatine phosphokinase (33), pyruvate kinase (34) etc., even though the increase of the biological activity of a protein molecule, such as the conversion of the inactive form of glycosylation inhibiting factor into its bioactive derivatives, has been reported to occur upon -SH modification (35) . Since AMP-deaminase regulation is crucial for the maintenance of the correct red blood cell energy state, we believe that our results represent a new and important improvement either of the knowledge of ROS damaging activity towards biologically fundamental molecules, or of the understanding of erythrocyte energy metabolism functioning in physiopathological conditions of increased oxidative stress.
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Table I
Residual activation of ROS activated AMP-deaminase by sulfhydryl agents and residual activation of sulfhydryl agent-treated AMP-deaminase by ROS .
Hydrogen peroxide-treated hemolysates (incubation with 1 mM NaN 3 + 4 mM H 2 O 2 for 15 min at 37 °C) were challenged for 60 min at 37 °C with 20 mM iodoacetate or 1 mM NEM.
Iodoacetate ( 
